Sanofi
41.60USD
-0.3600 (-0.86%)
Computing valuation metrics…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on SNY.
Valuation
P/E (TTM)
25.18x
P/E (Forward)
7.96x
EV/EBITDA
7.68x
EV/Revenue
2.40x
P/S (TTM)
2.04x
P/B
1.44x
FCF Yield
7.03%
Dividend Yield
5.82%
Gross Margin
72.77%
Operating Margin
20.58%
Net Margin
8.09%
Peer Comparison — Drug Manufacturers - General
| Company | Mkt Cap | P/E | EV/EBITDA | FCF Yield | Rev Growth | Div Yield |
|---|---|---|---|---|---|---|
| SNYSanofi | $99.68B | 25.18x | 7.68x | 7.03% | 14.58% | 5.82% |
| LLYEli Lilly and Company | $1.14T | 42.75x | 28.32x | 0.97% | 47.70% | 0.54% |
Subject metrics from SEC filings where available; peer metrics from cached market data.
| $635.07B |
| 40.03x |
| 19.20x |
| 2.91% |
| 5.90% |
| 2.03% |
| ABBVAbbVie Inc. | $504.76B | 80.69x | 18.50x | 3.34% | 10.20% | 2.42% |
| MRKMerck & Co., Inc. | $358.41B | 115.29x | 14.04x | 4.23% | 5.10% | 2.34% |
| NVSNovartis AG | $287.24B | 22.83x | 14.24x | 4.14% | 0.80% | 3.14% |
| AMGNAmgen Inc. | $237.48B | 27.28x | 16.26x | 3.64% | 9.50% | 2.29% |
| GILDGilead Sciences, Inc. | $193.48B | — | 14.71x | 5.05% | 10.20% | 2.10% |
| PFEPfizer Inc. | $171.16B | 39.00x | 8.79x | 7.29% | 2.60% | 5.73% |